1. Homepage
  2. Equities
  3. China
  4. Shanghai Stock Exchange
  5. Bluestar Adisseo Company
  6. Summary
    600299   CNE000001253

BLUESTAR ADISSEO COMPANY

(600299)
  Report
End-of-day quote Shanghai Stock Exchange  -  2022-08-07
9.260 CNY   +0.22%
08/01UBS Upgrades Bluestar Adisseo to Buy From Neutral, Adjusts Price Target to 13 Yuan From 14.2 Yuan
MT
07/28BLUESTAR ADISSEO : Continued growth in revenue (+20%) and net profit (+6.5%) despite challenging macro-environment
PU
07/28Bluestar Adisseo Company Reports Earnings Results for the Half Year Ended June 30, 2022
CI
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote Shanghai Stock Exchange
08/02/2022 08/03/2022 08/04/2022 08/05/2022 08/08/2022 Date
9.13 8.99 9.18 9.24 9.26 Last
11316920 7614618 5181734 4276480 3883091 Volume
-3.39% -1.53% +2.11% +0.65% +0.22% Change
Estimated financial data (e)
Sales 2022 14 421 M 2 136 M 2 136 M
Net income 2022 1 954 M 289 M 289 M
Net cash position 2022 4 337 M 642 M 642 M
P/E ratio 2022 15,9x
Yield 2022 2,61%
Sales 2023 15 727 M 2 330 M 2 330 M
Net income 2023 2 088 M 309 M 309 M
Net cash position 2023 3 667 M 543 M 543 M
P/E ratio 2023 12,8x
Yield 2023 3,79%
Capitalization 24 834 M 3 679 M 3 679 M
EV / Sales 2022 1,42x
EV / Sales 2023 1,35x
Nbr of Employees 2 455
Free-Float 13,6%
More Financials
Company
Bluestar Adisseo Co is a China-based company principally engaged in the research, design, production and distribution of additives for animal nutrition. The Company’s products include functional products, special products and others. Its functional products include methionine, vitamins, ammonia sulfates, as well as sodium sulfates, among others. Its special products include enzyme preparations, organic selenium... 
Sector
Pharmaceuticals
Calendar
10/27Earnings Release
More about the company
Ratings of Bluestar Adisseo Company
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
B-
More Ratings
All news about BLUESTAR ADISSEO COMPANY
08/01UBS Upgrades Bluestar Adisseo to Buy From Neutral, Adjusts Price Target to 13 Yuan From..
MT
07/28BLUESTAR ADISSEO : Continued growth in revenue (+20%) and net profit (+6.5%) despite chall..
PU
07/28Bluestar Adisseo Company Reports Earnings Results for the Half Year Ended June 30, 2022
CI
07/01BLUESTAR ADISSEO : First industrial-scale FeedKind® facility heralds new era of food secur..
PU
04/28Bluestar Adisseo Company Reports Earnings Results for the First Quarter Ended March 31,..
CI
04/21BLUESTAR ADISSEO : Adisseo Provides Stable Support for Pandemic Prevention and Product Sup..
PU
03/30Bluestar Adisseo Company Reports Earnings Results for the Full Year Ended December 31, ..
CI
03/15BLUESTAR ADISSEO : Adisseo Operation in Europe Fully Sustained
PU
02/17FY2021 : Solid growth in sales and net profit contributed to shareholders in a volatile an..
PU
01/06BLUESTAR ADISSEO : Chairman Hao Zhigang Shared Adisseo Case with CEIBS GEMBA Students
PU
2021BLUESTAR ADISSEO : Adisseo Awarded“2021 Annual Outstanding Practice Case of Office o..
PU
2021BLUESTAR ADISSEO COMPANY(SHSE : 600299) dropped from Shanghai Stock Exchange Health Care S..
CI
2021BLUESTAR ADISSEO : Adisseo's methionine plant in China celebrates its first 1 million tonn..
PU
2021Hao Zhigang, Chairman of Bluestar Adisseo, met with Liu Lei, Secretary of the Party Com..
PU
2021Q3 2021 : Double-digit growth in revenues and net profit
PU
More news
News in other languages on BLUESTAR ADISSEO COMPANY
07/28Bluestar Adisseo Company annonce ses résultats pour le semestre clos le 30 juin 2022
04/28Bluestar Adisseo Company annonce ses résultats pour le premier trimestre clos le 31 mar..
03/30Bluestar Adisseo Company annonce ses résultats pour l'année complète se terminant le 31..
2020Bluestar Adisseo Company annonce un dividende en espèces pour 2019, payable le 12 juin ..
2018Bluestar Adisseo Company fournit des prévisions de bénéfices non audités pour l'année 2..
More news
Analyst Recommendations on BLUESTAR ADISSEO COMPANY
More recommendations
Chart BLUESTAR ADISSEO COMPANY
Duration : Period :
Bluestar Adisseo Company Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends BLUESTAR ADISSEO COMPANY
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 6
Last Close Price 9,26 CNY
Average target price 14,22 CNY
Spread / Average Target 53,6%
EPS Revisions
Managers and Directors
Jean-Marc Dublanc Vice Chairman & General Manager
Yun Cai Chief Financial Officer
Zhi Gang Hao Vice Chairman
Yan Wang Member-Supervisory Board
Yuan Ding Independent Director
Sector and Competitors
1st jan.Capi. (M$)
BLUESTAR ADISSEO COMPANY-24.84%3 665
ZOETIS-28.45%81 742
ELANCO ANIMAL HEALTH INCORPORATED-31.50%9 216
DECHRA PHARMACEUTICALS PLC-32.81%4 903
VIRBAC-12.60%3 183
CHINA ANIMAL HUSBANDRY INDUSTRY CO., LTD.-1.53%1 924